4-Methylpyrazole-mediated inhibition of cytochrome P450 2E1 protects renal epithelial cells, but not bladder cancer cells, from cisplatin toxicity
Toxicological Sciences · 2025
DOI: 10.1093/toxsci/kfaf053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Jephte Y Akakpo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, United States. Hauptthemen laut MEDLINE: Cisplatin, Cytochrome P-450 CYP2E1, Urinary Bladder Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, Leo and Anne Albert Charitable Trust.
Abstract (Originalsprache)
Cisplatin is an effective chemotherapeutic drug for the treatment of bladder cancer, though cisplatin-induced nephrotoxicity (CIN) occurs in ∼20% to 30% of patients, limiting its clinical use. Evidence has shown that cytochrome P450 2E1 (CYP2E1), a drug metabolism enzyme expressed in proximal tubules, mediates the production of reactive oxygen species during cisplatin-induced injury. Previously, we showed that the repurposed drug 4-methylpyrazole (4MP) blocks CYP2E1 activity. Here, we investigated the potential protective effects of 4MP against CIN. Male and female C57BL/6J mice were treated intraperitoneally (i.p.) with a single 20 mg/kg dose of cisplatin for 3 days or 9 mg/kg/wk for 4 wk with or without 50 mg/kg 4MP as a co-treatment. Our findings revealed that acute treatment with cisplatin induced severe histological tubular damage and elevated plasma BUN and creatinine levels in male but not female mice. This difference correlated with higher basal CYP2E1 expression in the kidneys of male mice compared with female mice. We also found that cisplatin increased renal CYP2E1 activity and that inhibition of CYP2E1 with 4MP significantly reduced cisplatin-induced cell death in male mice and primary normal human kidney cells. By contrast, human bladder cancer cells do not express CYP2E1, and treatment with 4MP did not interfere with cisplatin’s anticancer effects in human bladder cancer HTB9 cells. This study highlights the critical role of CYP2E1 in CIN and suggests that its inhibition with 4MP in the kidney is a potential prophylactic therapeutic option to prevent CIN in bladder cancer patients without affecting its antineoplastic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, United States.
- Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, United States.
- Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United States.
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ 66160, United States.
- Coit Center for Longevity and Neurotherapeutics, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ 85719, United States.
- BIO5 Institute, College of Medicine, University of Arizona, Tucson, AZ 85719, United States.
ORCID-Profile: Jephte Y Akakpo, Anup Ramachandran
Förderung
- NIH HHS
- NCATS NIH HHS
- Leo and Anne Albert Charitable Trust
- Research Resource Consortium
- University of Kansas for Frontiers: University of Kansas Clinical and Translational Science Institute
- National PKD
- NIDDK NIH HHS
- NIEHS NIH HHS
Zitieren
APA
Akakpo, J. Y., Abbott, E., Woolbright, B. L., Ramachandran, A., Schnellmann, R. G., Wallace, D. P., & Taylor, J. A. (2025). 4-Methylpyrazole-mediated inhibition of cytochrome P450 2E1 protects renal epithelial cells, but not bladder cancer cells, from cisplatin toxicity. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf053
Vancouver
Akakpo JY, Abbott E, Woolbright BL, Ramachandran A, Schnellmann RG, Wallace DP, et al. 4-Methylpyrazole-mediated inhibition of cytochrome P450 2E1 protects renal epithelial cells, but not bladder cancer cells, from cisplatin toxicity. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf053
BibTeX
@article{Akakpo2025,
author = {Akakpo, Jephte Y and Abbott, Erika and Woolbright, Benjamin L and Ramachandran, Anup and Schnellmann, Rick G and Wallace, Darren P and Taylor, John A},
title = {4-Methylpyrazole-mediated inhibition of cytochrome P450 2E1 protects renal epithelial cells, but not bladder cancer cells, from cisplatin toxicity},
journal = {Toxicological Sciences},
year = {2025},
doi = {10.1093/toxsci/kfaf053}
}
EUVIMED